Saniona AB/Skr SANION
08:00
10:05
12:15
14:20
16:25
1D1W1MYTD1Y5YMAX
About Saniona AB
Saniona AB is a biopharmaceutical company based in Sweden, focusing on the discovery and development of treatments for rare diseases of the central nervous system. Its core business involves the research and development of ion channel modulators, which are pivotal in influencing cellular activity and treating neurological disorders. Saniona's pipeline includes product candidates such as Tesomet for rare eating disorders and SAN711 for neuropathic pain disorders. The company leverages its proprietary ion channel drug discovery platform to enhance its development capabilities. Saniona's strategic approach is distinguished by its focus on niche medical conditions with high unmet needs, positioning itself uniquely within the pharmaceutical industry. Sources: Saniona official website and public disclosures.
Ticker
Skr SANION
Sector
Primary listing
XSTO
Employees
31
Headquarters
Glostrup, Denmark
Website
Saniona AB Metrics
BasicAdvanced
kr 3.6B
5.78
kr 4.56
1.33
-
Price and volume
Market cap
kr 3.6B
Beta
1.33
52-week high
kr 28.30
52-week low
kr 5.41
Average daily volume
937K
Financial strength
Current ratio
8.913
Quick ratio
8.862
Total debt to equity
0.039
Interest coverage (TTM)
109.53%
Profitability
EBITDA (TTM)
610.29
Gross margin (TTM)
99.30%
Net profit margin (TTM)
77.16%
Operating margin (TTM)
81.88%
Effective tax rate (TTM)
7.98%
Revenue per employee (TTM)
kr 23,970,000
Management effectiveness
Return on assets (TTM)
89.69%
Return on equity (TTM)
171.55%
Valuation
Price to earnings (TTM)
5.78
Price to revenue (TTM)
4.387
Price to book
5.28
Price to tangible book (TTM)
5.31
Price to free cash flow (TTM)
5.705
Free cash flow yield (TTM)
17.53%
Free cash flow per share (TTM)
4.619
Growth
Revenue change (TTM)
2,687.51%
Earnings per share change (TTM)
-592.55%
3-year revenue growth (CAGR)
268.45%
10-year revenue growth (CAGR)
47.24%
3-year earnings per share growth (CAGR)
-5.19%
10-year earnings per share growth (CAGR)
12.34%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Saniona AB stock?
Saniona AB (SANION) has a market cap of Skr3.6B as of February 02, 2026.
What is the P/E ratio for Saniona AB stock?
The price to earnings (P/E) ratio for Saniona AB (SANION) stock is 5.78 as of February 02, 2026.
Does Saniona AB stock pay dividends?
No, Saniona AB (SANION) stock does not pay dividends to its shareholders as of February 02, 2026.
When is the next Saniona AB dividend payment date?
Saniona AB (SANION) stock does not pay dividends to its shareholders.
What is the beta indicator for Saniona AB?
Saniona AB (SANION) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.